GS
MYGN icon

GAM Systematic’s Myriad Genetics MYGN Stock Holding History

GAM Systematic’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.72M Buy
47,542
+29,073
+157% +$829K 0.25% 147
2017
Q2 		$477K Buy
+18,469
New +$392K 0.07% 416
2016
Q3 		– Sell
-18,552
Closed -$568K – 663
2016
Q2 		$568K Sell
18,552
-637
-3% -$22.1K 0.14% 304
2016
Q1 		$718K Buy
19,189
+16,298
+564% +$614K 0.19% 222
2015
Q4 		$125K Sell
2,891
-9,517
-77% -$402K 0.04% 521
2015
Q3 		$465K Buy
+12,408
New +$440K 0.11% 361

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

GAM Systematic's MYGN Position: Q3 2017 in Review

GAM Systematic increased its Myriad Genetics (MYGN) stake by 157% in Q3 2017, buying an estimated $829K and bringing the position to 47,542 shares worth $1.72M. The position accounts for 0.25% of the portfolio, ranked #147.

GAM Systematic first reported a position in MYGN in Q3 2015 and has held it in 6 quarters since. 220 funds tracked by Wall St. Rank hold MYGN as of Q3 2017.

  • GAM Systematic held 47,542 shares of Myriad Genetics worth $1.72M as of Q3 2017.
  • GAM Systematic bought 29,073 Myriad Genetics shares in Q3 2017, an estimated $829K.
  • Myriad Genetics made up 0.25% of GAM Systematic's portfolio in Q3 2017, its #147 holding.
  • GAM Systematic first reported a position in Myriad Genetics in Q3 2015 and has held it in 6 quarters since.
  • 220 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.